focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 159.80
Ask: 160.00
Change: 4.80 (3.09%)
Spread: 0.20 (0.125%)
Open: 155.80
High: 160.80
Low: 154.80
Prev. Close: 155.20
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

15 Feb 2024 07:00

RNS Number : 1880D
Sabre Insurance Group PLC
15 February 2024
 

 

 

15 February 2024

 

Sabre Insurance Group plc

Trading Update

 

Sabre Insurance Group Plc ("Sabre" or the "Group"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the year ended 31 December 2023.

Since 2022 Sabre has taken rapid and decisive pricing actions to mitigate the on-going elevated claims inflation. Consequently, it now expects to deliver a strong result for 2023 as it continues to re-build toward its historical level of profitability.

The results are anticipated to meet or exceed current market expectations across almost all key measures, specifically:

- Gross Written Premium at c.£225m, representing 31% growth. Within this, core Motor Vehicle premium growth of circa 47%

- Profit to be towards or slightly above the upper end of current market expectations

- Strong capital generation leaving pre-dividend solvency capital ratio around 205%

Sabre is scheduled to present its audited full year results for 2023 on 19 March 2024.

 

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

FORWARD-LOOKING STATEMENTS DISCLAIMER

Cautionary statement

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Sabre's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to Sabre's business, results of operations, financial position, prospects, growth or strategies and the industry in which it operates.

Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, Sabre disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

The Sabre Insurance Group plc LEI number is 2138006RXRQ8P8VKGV98.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDDDGBDGSS
Date   Source Headline
11th Feb 202110:28 amRNSDirector/PDMR Shareholding
1st Feb 202110:02 amRNSHolding(s) in Company
12th Jan 202110:53 amRNSDirector/PDMR Shareholding
8th Jan 20219:44 amRNSHolding(s) in Company
11th Dec 20201:31 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:56 amRNSHolding(s) in Company
3rd Dec 20207:00 amRNSBoard Appointment
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
11th Nov 202012:07 pmRNSDirector/PDMR Shareholding
6th Nov 202011:39 amRNSHolding(s) in Company
6th Nov 202010:55 amRNSHolding(s) in Company
27th Oct 20203:47 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSDirector/PDMR Shareholding
13th Oct 20209:42 amRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSTrading Statement
11th Sep 202010:07 amRNSDirector/PDMR Shareholding
3rd Sep 20204:13 pmRNSDirector/PDMR Shareholding
1st Sep 20202:23 pmRNSDirector/PDMR Shareholding
28th Aug 202012:02 pmRNSPrice Monitoring Extension
27th Aug 202011:32 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirectorate Change
12th Aug 20203:50 pmRNSHolding(s) in Company
11th Aug 20201:15 pmRNSDirector/PDMR Shareholding
10th Aug 20204:00 pmRNSHolding(s) in Company
6th Aug 202012:14 pmRNSDirector/PDMR Shareholding - Correction
6th Aug 202010:11 amRNSDirector/PDMR Shareholding
6th Aug 20209:32 amRNSDirector/PDMR Shareholding
3rd Aug 202012:54 pmRNSDirector/PDMR Shareholding
28th Jul 20207:02 amRNSBoard appointment
28th Jul 20207:00 amRNSHalf-year Report
14th Jul 20204:13 pmRNSHolding(s) in Company
13th Jul 202012:51 pmRNSDirector/PDMR Shareholding
30th Jun 20201:33 pmRNSDirector/PDMR Shareholding
11th Jun 20201:59 pmRNSDirector/PDMR Shareholding
10th Jun 20209:57 amRNSDirector/PDMR Shareholding - Correction
4th Jun 20209:49 amRNSDirector/PDMR Shareholding
29th May 20203:39 pmRNSDirector/PDMR Shareholding
29th May 202012:37 pmRNSDirector/PDMR Shareholding
21st May 202012:17 pmRNSResult of AGM
21st May 20207:00 amRNSTrading Statement
13th May 20202:24 pmRNSDirector/PDMR Shareholding
12th May 202011:54 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSHolding(s) in Company
1st May 202011:58 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSNotice of AGM
24th Apr 202011:44 amRNSHolding(s) in Company
23rd Apr 20202:08 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSHolding(s) in Company
20th Apr 20201:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.